R Carter Pate insider trades: Option Care Health (OPCH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where R reports to the SEC
and 1 more company
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | OPCH | ↓ Sell | 30,287 | $32.05 | $971K | Direct | Mar 3, 2026 (4d) |
| Aug 20, 2025 | OPCH | ↑ Buy | 750 | $27.19 | $20K | Direct | Aug 21, 2025 (1d) |
| Sep 3, 2024 | OPCH | ↓ Sell | 1,465 | $32.37 | $47K | Direct | Sep 5, 2024 (2d) |
| Aug 17, 2023 | OPCH | ↑ Buy | 1,465 | $34.32 | $50K | Direct | Aug 21, 2023 (4d) |
| May 15, 2023 | PRPL | ↑ Buy | 16,949 | $2.95 | $50K | Direct | May 15, 2023 (0d) |
| Oct 3, 2022 | OPCH | ↓ Sell | 1,928 | $31.97 | $62K | Direct | Oct 5, 2022 (2d) |
| Sep 1, 2022 | OPCH | ↓ Sell | 1,923 | $30.65 | $59K | Direct | Sep 2, 2022 (1d) |
| Aug 1, 2022 | OPCH | ↓ Sell | 1,923 | $33.37 | $64K | Direct | Aug 3, 2022 (2d) |
| Jul 8, 2022 | OPCH | ↓ Sell | 1,923 | $30.00 | $58K | Direct | Jul 12, 2022 (4d) |
| Jun 1, 2022 | OPCH | ↓ Sell | 7,048 | $27.97 | $197K | Direct | Jun 3, 2022 (2d) |
| May 27, 2021 | TLGT | ↑ Buy | 30,000 | $0.55 | $16K | Direct | May 27, 2021 (0d) |
| May 10, 2021 | OPCH | ↑ Buy | 855 | $16.74 | $14K | Direct | May 12, 2021 (2d) |
| Nov 11, 2019 | PRSC | ↓ Sell | 1,000 | $69.67 | $70K | Direct | Nov 13, 2019 (2d) |
| Aug 13, 2019 | PRSC | ↑ Buy | 1,000 | $57.97 | $58K | Direct | Aug 15, 2019 (2d) |
| Nov 10, 2016 | BIOS | ↑ Buy | 20,000 | $1.30 | $26K | Direct | Nov 14, 2016 (4d) |
| Jun 17, 2016 | BIOS | ↑ Buy | 25,000 | $2.50 | $62K | Direct | Jun 20, 2016 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OPCH insiders
Open-market trades in the last 12 months
About R Carter Pate's insider trades
R Carter Pate is a director at Option Care Health (OPCH). Since Jun 17, 2016, R has reported 8 open-market purchases worth $298K and 8 sales worth $1.5M on SEC Form 4. In the last 12 months: 1 sale ($971K).
Their filings also include grants and awards (33 filings), shares returned to the company (3 filings), gifts (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPCH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.